Breathing treatment for recovery after spinal cord injury
Official title: Genetic Biomarkers of Intermittent Hypoxia-Induced Respiratory Motor Plasticity in Chronic SCI
Run by University of Florida · NCT06011876 · Data updated 2026-11-12
This study is testing if a new breathing treatment can help people with spinal cord injuries recover their breathing and movement better than a standard treatment.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 70 Years |
| Sex | All |
| Enrollment | 62 (estimated) |
| Sponsor | University of Florida Academic / other |
| Locations | 1 site (Jacksonville, Florida) |
| Status | Recruiting |
| Started | December 21, 2023 |
| Main results expected | July 2027 |
| Study ends | September 2027 |
| Registry record updated | September 14, 2026 |
| Trial ID | NCT06011876 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18-70 with chronic incomplete or complete spinal cord injuries lasting at least one year.
✕Probably not a fit
Patients with progressive spinal cord conditions or those outside the specified age range may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the effects of acute intermittent hypoxia (AIH) and acute intermittent hypercapnic-hypoxia (AIHH) on respiratory function and motor recovery in individuals with spinal cord injuries. Participants will undergo a series of tests and receive one of three interventions: AIH, AIHH, or a sham treatment, followed by assessments to measure changes in breathing and motor function. The study also includes respiratory strength training to enhance the effectiveness of the interventions. The goal is to determine if AIHH provides greater benefits compared to AIH and to explore how genetic variations may influence individual responses to these treatments.
Why it matters
Potential benefit: If successful, this treatment could significantly improve breathing and motor function in patients with spinal cord injuries.
How similar studies have gone: Previous studies have shown promising results with acute intermittent hypoxia approaches, suggesting potential for success in this novel application.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Adults 18-70 years of age 2. Chronic incomplete SCI ≥ 1 year at or below C1-T12 * Incomplete SCI based on residual sensory and motor function below the level of the injury or injury classification of B, C, D at initial screening according to the American Spinal Injury Association Impairment Classification and the International Standards for the Neurological Classification of SCI. -OR- Chronic complete SCI ≥1 year at or below C4-T12 * Complete SCI based on the absence of residual sensory or motor function below the level of injury or injury classification of A at initial screening according to the American Spinal Injury Association Impairment Classification and the International Standards for the Neurological Classification of SCI. 3. Medically stable with physician clearance 4. SCI due to non-progressive etiology 5. 20% impairment in maximal inspiratory, maximal expiratory pressure generation, or both relative to normative values Exclusion Criteria: 1. Current diagnosis of an additional neurologic condition such as Multiple Sclerosis, Parkinson disease, stroke, or brain injury 2. Severe illness or infection, including non-healing decubitus ulcers, untreated bladder or urinary tract infections, cardiovascular disease, lung disease, active heterotopic ossification, or uncontrolled hypertension 3. Severe neuropathic pain 4. Known pregnancy 5. Severe recurrent autonomic dysreflexia Exclusion for involvement in TMS - History of seizure disorder, uncontrolled migraines, presence of cardiac pacemaker, metal implants in skull, medications that lower seizure threshold.
Where it's running
-
Brooks Rehabilitation
Jacksonville, Florida, United States Recruiting
Study contacts
- Principal investigator: Emily Fox, DPT, MHS, PhD — University of Florida & Brooks Rehabilitation
- Study coordinator: Emily J Fox, PT, MHS, PhD
- Email: ejfox@phhp.ufl.edu
- Phone: 904-742-2500
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Transcutaneous spinal cord stimulation with 4-aminopyridine and intensive rehab for chronic spinal cord injury
This pilot study tests whether combining noninvasive spinal stimulation, dalfampridine, and rigorous rehab is safe and feasible for adults with chronic spinal cord injury and whether it can help improve movement and walking.
-
NG004 for incomplete cervical spinal cord injury
This trial tests NG004 versus placebo to see if it is safe and helps motor function and daily life in adults with acute incomplete cervical spinal cord injury.
-
Robot-assisted training for arm and leg movement after stroke or injury
This study tests whether adding ZEPU-AI robotic training to usual therapy is safe and helps adults with arm or leg movement problems from stroke, spinal cord injury, brain injury, or orthopedic conditions.
-
ZEPU-AI3 Lower Limb Feedback Training and Evaluation Robot in Rehab
This pilot trial tests whether adding the ZEPU-AI3 robotic leg training with real-time feedback to standard rehab helps adults with lower limb motor problems from stroke, spinal cord injury, or similar conditions.
-
Combined magnetic stimulation and ultrasound for detrusor overactivity in spinal cord injury
This study tests whether using high-frequency sacral nerve stimulation together with bladder-directed ultrasound can reduce involuntary bladder contractions and improve bladder function in people with spinal cord injury.
-
Hybrid HIIT-FES cycling program for people with spinal cord injury
This study tests a hybrid exercise program that combines functional electrical stimulation cycling with voluntary arm work to improve health in adults with spinal cord injury.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.